Cannabinoids & Endometriosis: Exploring a Novel Therapeutic Approach

Name: Cannabinoids & Endometriosis: Exploring a Novel Therapeutic Approach
Uploaded: 2025-05-16 19:31:27
Description: July 10, 2025 Join Dr. Bonni for an in-depth webinar examining the role of the endocannabinoid system in endometriosis and how cannabinoids may help modulate pain, inflammation, and immune dysregulation. We will review emerging research, clinical insights, and practical guidance for integrating cannabinoid-based therapies into care.

Education Webinars Cannabinoids & Endometriosis: Exploring a Novel Therapeutic Approach

July 10, 2025 Join Dr. Bonni for an in-depth webinar examining the role of the endocannabinoid system in endometriosis and how cannabinoids may help modulate pain, inflammation, and immune dysregulation. We will review emerging research, clinical insights, and practical guidance for integrating cannabinoid-based therapies into care.

Integrate Powerful Hemp Cannabinoids into your Healthcare Practice

Learn from leading cannabis clinician Bonni Goldstein, MD and grow your practice revenues through our lab-tested hemp extract marketplace, while providing an exclusive medical discount to your patients. For a limited time, our platform is free for licensed US healthcare practitioners only.

With your free account, you'll get access to this educational video and so much more!

Learn more Create your free account

View Sources

Anvari Aliabad, Roghayeh, Kamyab Hassanpour, and Amir Hossein Norooznezhad. "Cannabidiol as a Possible Treatment for Endometriosis through Suppression of Inflammation and Angiogenesis." Immunity, Inflammation and Disease, vol. 12, no. 8, 2024, e1370.

Armour, Mike, et al. "Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey." Journal of Women's Health, vol. 30, no. 10, 2021, pp. 1485–1492.

Armour, Mike, et al. "Self-Management Strategies amongst Australian Women with Endometriosis: A National Online Survey." BMC Complementary and Alternative Medicine, vol. 19, 2019, pp. 1–8.

Cecconi, Sandra, et al. "Endocannabinoid Signaling in Mammalian Ovary." European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 178, 2014, pp. 6–11.

Cobellis, Luigi, et al. "Effectiveness of the Association Micronized N-Palmitoylethanolamine (PEA)–Transpolydatin in the Treatment of Chronic Pelvic Pain Related to Endometriosis after Laparoscopic Assessment: A Pilot Study." European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 158, no. 1, 2011, pp. 82–86.

Dahlgren, M. Kathryn, et al. "A Survey-Based, Quasi-Experimental Study Assessing a High-Cannabidiol Suppository for Menstrual-Related Pain and Discomfort." NPJ Women's Health, vol. 2, no. 1, 2024, p. 29.

Dmitrieva, Natalia, et al. "Endocannabinoid Involvement in Endometriosis." PAIN®, vol. 151, no. 3, 2010, pp. 703–710.

Escudero-Lara, Alejandra, et al. "Disease-Modifying Effects of Natural Δ9-Tetrahydrocannabinol in Endometriosis-Associated Pain." eLife, vol. 9, 2020, e50356.

Farooqi, Toobah, et al. "Cannabis and endometriosis: the roles of the gut microbiota and the endocannabinoid system." Journal of clinical medicine 12.22 (2023): 7071.

Genovese, T., et al. "Molecular and Biochemical Mechanism of Cannabidiol in the Management of the Inflammatory and Oxidative Processes Associated with Endometriosis." International Journal of Molecular Sciences, vol. 23, 2022, p. 5427.

Indraccolo, Ugo, and Fabrizio Barbieri. "Effect of Palmitoylethanolamide–Polydatin Combination on Chronic Pelvic Pain Associated with Endometriosis: Preliminary Observations." European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 150, no. 1, 2010, pp. 76–79.

Jasinski, Victoria, et al. "Cannabis Use in Endometriosis: The Patients Have Their Say—An Online Survey for German-Speaking Countries." Archives of Gynecology and Obstetrics, vol. 310, no. 5, 2024, pp. 2673–2680.

Leconte, Mahaut, et al. "Antiproliferative Effects of Cannabinoid Agonists on Deep Infiltrating Endometriosis." The American Journal of Pathology, vol. 177, no. 6, 2010, pp. 2963–2970.

Lingegowda, H., et al. "Role of the Endocannabinoid System in the Pathophysiology of Endometriosis and Therapeutic Implications." Journal of Cannabis Research, vol. 4, no. 1, 2022, p. 54.

Okten, Sabri Berkem, et al. "Cannabidiol as a Potential Novel Treatment for Endometriosis by Its Anti-Inflammatory, Antioxidative and Antiangiogenic Effects in an Experimental Rat Model." Reproductive BioMedicine Online, vol. 46, no. 5, 2023, pp. 865–875.

Proudfoot, Andrew, et al. "A Survey of Cost, Access and Outcomes for Cannabinoid‐Based Medicinal Product Use by Australians with Endometriosis." Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 64, no. 4, 2024, pp. 411–415.

Rier, Sherry E., et al. "Endometriosis in Rhesus Monkeys (Macaca mulatta) Following Chronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin." Fundamental and Applied Toxicology, vol. 21, no. 4, 1993, pp. 433–441.

Sinclair, Justin, et al. "Cannabis Use, a Self-Management Strategy among Australian Women with Endometriosis: Results from a National Online Survey." Journal of Obstetrics and Gynaecology Canada, vol. 42, no. 3, 2020, pp. 256–261.

Sinclair, Justin, et al. "‘In the Weeds’: Navigating the Complex Concerns, Challenges and Choices Associated with Medicinal Cannabis Consumption for Endometriosis." Reproduction and Fertility, vol. 6, no. 2, 2025.

Soave, I., and R. Marci. "Administration of Micronized Palmitoylethanolamide (PEA)-Transpolydatin in the Treatment of Chronic Pelvic Pain in Women Affected by Endometriosis: Preliminary Results." Minerva Ginecologica, 2013. [Volume/issue/page numbers missing]

Stochino Loi, Emanuela, et al. "Effect of Ultramicronized-Palmitoylethanolamide and Co-Micronized Palmitoylethanolamide/Polydatin on Chronic Pelvic Pain and Quality of Life in Endometriosis Patients: An Open-Label Pilot Study." International Journal of Women's Health, 2019, pp. 443–449.

Collapse